Cancers, Vol. 14, Pages 2776: Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future
Cancers, Vol. 14, Pages 2776: Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future
Cancers doi: 10.3390/cancers14112776
Authors:
Karla Alfaro
Montserrat Soler
Mauricio Maza
Mauricio Flores
Leticia López
Juan C. Rauda
Andrea Chacón
Patricia Erazo
Nora Villatoro
Eveline Mumenthaler
Rachel Masch
Gabriel Conzuelo
Juan C. Felix
Miriam Cremer
Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low- and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country’s disease burden. While the World Health Organization’s (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO’s strategic target...
Source: Cancers - Category: Cancer & Oncology Authors: Karla Alfaro Montserrat Soler Mauricio Maza Mauricio Flores Leticia L ópez Juan C. Rauda Andrea Chac ón Patricia Erazo Nora Villatoro Eveline Mumenthaler Rachel Masch Gabriel Conzuelo Juan C. Felix Miriam Cremer Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Covid Vaccine | COVID-19 | El Salvador Health | International Medicine & Public Health | Pandemics | Vaccines | WHO